• Work and Wellbeing Bounce Back during Coronavirus Crisis

    Government measures to arrest the economic impact of COVID-19 have helped stop further job losses and declines in working hours, new analysis from The Australian National University (ANU) shows.  The steadier jobs outlook has also boosted Australians’ sense of wellbeing. The Australian National University says that the analysis builds on a first-of-its-kind longitudinal ANU survey in April, which showed more than 670,000 Australians had lost their jobs due to the crisis - an unprecedented drop in employment.  The new survey shows since April there have essentially been no net job losses, with employment sitting at around 58 per cent.  Australians who are working have slightly increased their number of hours worked, jumping from 32.3 hours per week in April to 32.8 per week in May.  

  • Pandemic-Fueled Job Losses Exacerbating Preexisting Inequalities among Workers

    The sharp spike in job losses due to the COVID-19 pandemic were disproportionately concentrated in lower-paying occupations and industries, with the most acute impact felt among women, minorities, younger workers and less-educated workers, according to new research co-written by a University of Illinois at Urbana-Champaign labor economist. The University of Illinois at Urbana-Champaign says that while some of the highest-paid occupations saw only negligible declines in employment, nearly all occupations in the bottom quartile of the occupational wage distribution experienced steep employment declines through April, indicating that the pandemic is exacerbating preexisting inequalities among workers.

  • U.S. orders states to report demographic data, after disproportionate effects of the virus

    The Trump administration on Thursday released new requirements for states to report coronavirus data based on race, ethnicity, age and sex of individuals tested for the virus, in an effort to respond to demands from lawmakers for a better picture of the pandemic. The New York Times reports that all laboratories — as well as nonlaboratory facilities offering on-site testing and in-home testing — will be required to send demographic data to state or local public health departments based on the individual’s residence, according to details released by the Department of Health and Human Services.

  • “This Is What Happens to Us”: How U.S. Cities Lost Precious Time to Protect Black Residents from the Coronavirus

    Interviews with nearly 60 public health experts, lawmakers and community leaders show that many of the first coronavirus testing sites went up in areas that happened to be whiter and more affluent, despite the requests of black leaders. Robert Samuels, Aaron Williams, Aaron Williams, and Aaron Williams, Tracy Jan, and Jose A. Del Real write in the Washington Post that local governments — sometimes ignoring the pleas of community activists — targeted few of their education campaigns about prevention and social distancing specifically to African Americans, even as conspiracy theories spread that black people were immune to the disease. Poor reporting of data, which initially masked the fact that the disease was disproportionately affecting black communities, remains a problem even as states move to reopen their economies.

  • Will Movie Theaters Survive COVID-19?

    “COVID-19 has exacerbated longstanding issues that have been shaping the economics of movie exhibition for some time. Independent theaters and smaller chains were already struggling after the transition to digital projection a decade ago and increased competition from mobile devices and streaming platforms. We’ve seen the impact of that decline recently with the bankruptcy of Goodrich Quality Theaters, a Midwest-based chain. Even some of the big chains like AMC might not survive if COVID-19 keeps moviegoers out of theaters into the fall and winter,” says Derek Long, aprofessor of media and cinema studies at University of Illinois at Urbana-Champaign. “Regardless of what eventually happens with the virus, exhibitors will be forced to find new ways of making the theatrical experience appealing. Theaters and moviegoing won’t disappear. But they could look very different.”

  • More Evidence Remdesivir Helps Some Coronavirus Patients

    A five-day course of the antiviral drug remdesivir sped recovery in moderately ill patients with pneumonia from Covid-19, drugmaker Gilead Sciences announced in a statement Monday. John Bonifield and Jacqueline Howard write for CNN that this is more evidence that the drug can help patients, however outside experts are not calling this a “game changer” quite yet. Coronavirus patients who were hospitalized, but not sick enough to need oxygen from a ventilator, were more likely to recover after a five-day course of remdesivir than those given the current standard of care alone, Gilead said.

  • Heightened Risks When Pandemic and Hurricane Season Overlap

    Researchers studying the ability of coastal communities to respond to disasters say that combined disasters may make community recovery vastly more difficult. What they have found serves as a stark warning to policymakers preparing for hurricane season during a pandemic. One of the main worries is that there will be significant delays in recovery efforts if front-line workers are not kept healthy.

  • Patients Who Test Negative for Antibodies May Still Have Immunity against Coronavirus, Scientists Warn

    Patients who test negative for antibodies may still have immunity against coronavirus, scientists have warned. Phoebe Southworth writes in The Telegraph that white blood cells in the mouth and throat which fight off viruses, known as T cells, are produced when a person comes into contact with Covid-19, acting as a first line of defense, according to a study in the academic journal Cell. This means the body may never need to produce antibodies to fight

  • Architect of Sweden's Coronavirus Plan Warns U.K. Not to Hold Out for A Vaccine

    Waiting for a coronavirus vaccine is a risky strategy, the architect of Sweden’s Covid-19 plan has warned, saying measures that are “sustainable and can be kept going for a long time” must be put in place to protect the public. Hannah Boland writes in The Telegraph that Anders Tegnell, Sweden’s chief epidemiologist who was responsible for the country’s decision to keep its economy open and avoid a lockdown, told The Telegraph: “A lot of people claim that the Swedish strategy is very risky, but I would say that putting so much faith in a vaccine is also quite risky.”

  • First Human Trial of COVID-19 Vaccine Finds It Is Safe and Induces Rapid Immune Response

    The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published in The Lancet. MedicalExpress quotes The Lancet to say that the open-label trial in 108 healthy adults demonstrates promising results after 28 days—the final results will be evaluated in six months. Further trials are needed to tell whether the immune response it elicits effectively protects against SARS-CoV-2 infection.

  • Sewage Could Hold the Key to Stopping New Coronavirus Outbreaks

    The vast brown rivers of sludge that gush into the sewage treatment plants across Germany may hold a key to early detection of any new wave of the coronavirus, scientists tell CNN. Fred Pleitgen writes for CNN that the Helmholtz Center for Environmental Research is leading a trial that’s sampling wastewater from plants serving some of the largest urban areas and trying to find evidence of the coronavirus. The ultimate goal is for almost all sewage plants to install these coronavirus early warning systems so as to track the spread of Covid-19.

  • Long after the Illness Is Gone, the Damage from Coronavirus May Remain

    The roulette wheel of infection that determines which COVID-19 patients live and die has gripped the world in fear, but researchers are looking into another insidious danger — that the disease could be inflicting lasting, even permanent, damage on its victims. Peter Fimwrite writes in the San Francisco Chronicle that infectious disease specialists have learned that the health problems caused by the coronavirus sometimes linger for months, raising fears that the virus may have long-term consequences for people’s health.

  • Nursing Homes Site of 40% of U.S. COVID-19 Deaths

    A new analysis in USA Today suggests up to 40% of US deaths from COVID-19 have taken place in nursing homes or long-term care facilities, a staggering statistic that represents 40,600 residents. More than 2.4 million Americans live in long-term care facilities. Stephanie Soucheray writes in CIDRAP that this means roughly 450 residents of these facilities have died each day from COVID-19 since March. But the newspaper said this is likely an undercount, as state reporting is inconsistent. Texas, Virginia, and Arizona, for example, have still not released facility-level data.

  • Treating Mild Coronavirus Cases Could Help Save Everyone

    President Trump’s announcement two weeks ago that he was taking the antimalarial drug hydroxychloroquine as a measure against Covid-19, if true, is puzzling, because  scientific evidence is growing that the drug offers no benefit to Covid-19 patients and could be dangerous. Richard Malley and Marc Lipsitch write in the New York Times that Trump’s decision does highlight the urgent need to devote more attention and resources to drugs that can prevent COVID-19 or stop mild cases from getting worse. There is an urgent need to help the people most severely affected, but we think a parallel effort is equally urgent: conducting clinical trials to identify drugs that could prevent people from becoming infected with SARS-CoV-2 in the first place or prevent mild cases of Covid-19 from becoming severe.

  • Virality Project (US): Marketing Meets Misinformation

    Pseudoscience and government conspiracy theories swirl on social media, though most of them stay largely confined to niche communities. In the case of COVID-19, however, a combination of anger at what some see as overly restrictive government policies, conflicting information about treatments and disease spread, and anxiety about the future has many people searching for facts…and finding misinformation. This dynamic creates an opportunity for determined people and skilled marketers to fill the void - to create content and produce messages designed to be shared widely.